On Tuesday, May 28, Qualcomm asked a federal judge not to enforce her decision that it illegally squeezed out rivals in the smartphone chips market as it plans to file an appeal that could take more than a year to wind through the courts, reported Reuters.
In a filing in federal court in San Jose, California, Qualcomm stated that it believes it can succeed in appealing the May 21 decision by US District Judge Lucy Koh in an antitrust case brought by the US Federal Trade Commission (FTC) in January 2017. The company has not yet filed that appeal; Tuesday’s filing only concerns whether the ruling’s provisions will be put on hold temporarily as it plays out.
Qualcomm argued that Koh’s ruling raised “serious legal questions” because, among other things, she excluded evidence after a March 2018 cutoff date—including the fact that Apple dropped Qualcomm in favor of rival chip supplier Intel—showing that Qualcomm did not have a stranglehold on the market. Qualcomm also claimed that the FTC’s theory in the lawsuit – that Qualcomm’s patent licensing practices amounted to a “tax” on smartphone makers—generating profits that Qualcomm then put to work undercutting its rivals—was unprecedented in antitrust law.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas